Review Article
Exosomes in the Oncobiology, Diagnosis, and Therapy of Hepatic Carcinoma: A New Player of an Old Game
Table 1
Exosome-mediated cellular interaction involved in liver cancer.
| Donor cells | Components | Recipient cells | Functions | References |
| HKCI-C3 HKCI-8 MHCC-97L | MET proto-oncogene, caveolins, S100 family | MIHA | Migration, invasion | [13] |
| Huh7 | miR-122 | HepG2 | Proliferation | [14] |
| HepG2 | VASN | HUVECs | Migration | [15] |
| CD90+ Huh7 | lncRNA H19 | HUVECs | Angiogenesis, adhesion | [16] |
| CAFs | miR-320a | MHCC97-H | Proliferation, migration, metastasis | [17] |
| CSQT-2 HCC-LM3 | miR-1247-3p | Normal fibroblasts | Conversion into CAFs | [18] |
| LX-2 | miR-335 | MHCC97H, MHCC97L, HepG2 and Huh7 | Proliferation, invasion, tumor shrinkage | [19] |
| Hepa1-6 | α-AFP, glypican 3, HSP 70 | DCs | T cell activation | [20] |
| Gastric cancer | EGFR | Kupffer cells HSCs | Liver metastasis | [21] |
| Pancreatic ductal adenocarcinoma | MIF | Kupffer cells HSCs | Liver metastasis | [22] |
| Breast cancer | integrin αvβ5 | Kupffer cells | Liver metastasis | [23] |
| Colorectal cancer | miR-203 | M2-TAMs | Liver metastasis | [24] |
| MHCC-97H | HGF | SMCC-7721 | Chemoresistance | [25] |
| HepG2 | linc-ROR | HepG2 | Chemoresistance | [26] |
| HepG2 | linc-VLDLR | HepG2 | Chemoresistance | [27] |
| ADMSCs | miR-122 | HepG2 | Sorafenib sensistivity | [28] |
|
|
ADMSCs: adipose-derived mesenchymal stem cells; CAFs: cancer associated fibroblasts; DCs: dendritic cells; HSCs: hepatic stellate cells; HUVECs: human umbilical vein endothelial cells; H22: murine hepatocarcinoma cell line; LX-2: hepatic stellate cells line; MIF: macrophage migration inhibitory factor; MIHA: immortalized hepatocyte cell line; and TAMs: tumor-associated macrophages.
|